ArticleInternational journal of clinical pharmacy2020

Dipeptidyl peptidase-4 inhibitors and risk of venous thromboembolism: data mining of FDA adverse event reporting system.

Wenchao Lu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.